 Administration, Oral
"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 9 | 9 | | 1996 | 0 | 8 | 8 | | 1997 | 0 | 7 | 7 | | 1998 | 0 | 10 | 10 | | 1999 | 0 | 4 | 4 | | 2000 | 0 | 7 | 7 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 12 | 12 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 15 | 15 | | 2006 | 0 | 9 | 9 | | 2007 | 0 | 22 | 22 | | 2008 | 0 | 19 | 19 | | 2009 | 0 | 14 | 14 | | 2010 | 0 | 27 | 27 | | 2011 | 0 | 20 | 20 | | 2012 | 0 | 30 | 30 | | 2013 | 0 | 20 | 20 | | 2014 | 0 | 29 | 29 | | 2015 | 0 | 25 | 25 | | 2016 | 0 | 35 | 35 | | 2017 | 0 | 31 | 31 | | 2018 | 0 | 45 | 45 | | 2019 | 1 | 37 | 38 | | 2020 | 0 | 33 | 33 | | 2021 | 0 | 24 | 24 | | 2022 | 0 | 6 | 6 | | 2023 | 0 | 9 | 9 | | 2024 | 0 | 17 | 17 | | 2025 | 0 | 21 | 21 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Singh S, Singh AK, Singh AN, Singh SK, Yadav VB, Gangwar M, Sahu M, Kumar D, Nath G. Efficacy of bacteriophage cocktails administered through mucosal and non-mucosal routes for urinary tract infections caused by Enterobacter cloacae: A preclinical study. Microb Pathog. 2025 Dec; 209:108024.
-
Brooks Peterson M, Boyd J, Zhu A, Bothwell S, Prager JD. Seeking a Viable Alternative: A Prospective, Randomized, Controlled, Double-Blind Non-Inferiority Study of Oral Versus IV Dexamethasone in Children Undergoing Tonsillectomy. Paediatr Anaesth. 2025 Nov; 35(11):953-961.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
-
Kumari N, Panja S, Kumar B, Ahmad R, Kollala SS, Siddhanta K, Islam F, Joshi V, Talmon GA, Murry DJ, Singh AB, Oupický D. Reactive Oxygen Species-Responsive Polymeric Chloroquine Nanogel for Targeted Oral Therapy of Ulcerative Colitis. ACS Appl Mater Interfaces. 2025 Sep 10; 17(36):50443-50463.
-
Wallace BI, England BR, Baker JF, George MD, Sauer BC, Rojas J, Roul P, Wysham KD, Brubeck H, Smith I, Caplan L, Monach PA, Kerr GS, Kunkel G, Braaten T, Mikuls TR, Cannon GW. Agreement of Administrative Pharmacy Dispensing With Self-Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2025 Nov; 77(11):1350-1358.
-
Ashur C, Qin L, Minges KE, Freeman JV, Al-Khatib SM, Bradley SM, Ho PM, Tzou WS, Varosy PD, Hess PL, Sandhu A. Use of Direct Oral Anticoagulants Following Cardiac Implantable Electronic Device Placement. Pacing Clin Electrophysiol. 2025 Aug; 48(8):859-869.
-
Hamilton EP, Patel MR, Borges VF, Meisel JL, Okera M, Alemany CA, Pluard TJ, Wesolowski R, Sabanathan D, Miller KD, Conlin AK, McCarthy N, Shaw M, Tonda M, Shilkrut M, Lin NU. Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2-?advanced or metastatic breast cancer: phase 1/2 study results. Breast Cancer Res. 2025 Jul 01; 27(1):119.
-
Craig A, Shihadeh KC, Knepper BC, Miller W, Young HL, Aragon D, Jenkins TC. Antibiotic adherence and treatment completion associated with partial oral therapy versus all intravenous therapy in patients with serious Staphylococcus aureus infections. BMC Infect Dis. 2025 May 17; 25(1):714.
-
Kessler ER, Wulff-Burchfield E, Phillips J, Peters W, McGowan T, Aggarwal P. Elevating the Patient Voice: Understanding Treatment Preferences in Patients with Advanced Prostate Cancer. Adv Ther. 2025 Jul; 42(7):3240-3248.
-
Mondal K, Gary AA, Dash A, Del Mar NA, Stephenson DJ, Chalfant CE, Reiner A, Sears B, Mandal N. Oral Supplementation of n-3 Polyunsaturated Fatty Acids (n-3-PUFA) Can Prevent TBI-Induced Visual, Motor, and Emotional Deficits in Mice. Mol Neurobiol. 2025 Sep; 62(9):11972-11985.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|